WJPR Citation New

  All Since 2019
 Citation  7475  4312
 h-index  28  21
 i10-index  197  83

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

MOLECULAR TARGETS OF METFORMIN IN TRIPLE NEGATIVE BREAST CANCER: A REVIEW

Ayushi* and Avantika Jain

.

Abstract

Triple negative breast cancers are the type of breast cancers which are negative for expression of the steroid receptors estrogen and progesterone as well as tyrosine kinase receptor HER-2. Since TNBC is an aggressive cancer and has shortage of specific therapeutic options, there is a need to peruse the ways in which TNBC develops and how it can be treated by using specific molecular targets. Extremely low glucose concentration and calorie restriction have shown to enhance the anti-tumorigenic effect of cancer. Metformin is being used for a very long time for the treatment of type-2 diabetes mellitus and its therapeutic effects include the maintenance of normal blood glucose levels. Therefore, in the current report, we will try to compile and explore the possible mechanism of metformin’s anticancer profile against TNBC with thorough crosstalk among the existing research conducted in metformin in both preclinical and clinical settings.

Keywords: Triple negative breast cancer, metformin, molecular targets, clinical trials, preclinical trials.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More